Sale of BioReference brings $722 million in cash as the company narrows its focus to biotech.
Opko Health Inc. (OPK) News
Latest headlines that mention OPK, newest first · each headline opens the original publisher
- Last price
- $1.76
- Day change
- +1.73%
- Next earnings
- —
OPK headlines
last 30 daysAlso mentioned with OPK
30dHeadlines that tag both tickers
OPK news alerts
Get an alert by email or push when a new headline mentions OPK.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.